+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Vascular injury, hypertension and coronary artery disease in human immunodeficiency virus infection



Vascular injury, hypertension and coronary artery disease in human immunodeficiency virus infection



La Clinica Terapeutica 159(1): 51-55



The atherogenic effects of some highly active antiretroviral therapy (HAART) regimens, especially those including protease inhibitors (PI), may synergistically promote the acceleration of cardiovascular disease and increase the risk of death from cardiovascular events even in young HIV-infected people. Along with the endothelial dysfunction associated with visceral fat accumulation and related metabolic alterations of HIV-lipodystrophy syndrome (eg, insulin resistance), vascular injury has been associated with HIV-1 infection itself, with an autoimmune reaction to viral infection (vasculitis) and with a direct action of drugs included in HAART regimens. Clinical studies suggest that HIV-infected patients under PI-including HAART and with preexisting cardiovascular risk factors, should be considered at risk for developing coronary artery disease, and that this risk increases with the time of exposure to HAART. A careful cardiovascular screening and monitoring of HIV-infected patients receiving HAART is needed according to the most recent clinical guidelines.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 056854960

Download citation: RISBibTeXText

PMID: 18399263


Related references

Coronary artery disease and human immunodeficiency virus infection. Clinical Infectious Diseases 31(3): 787-797, 2000

Quantitative angiographic characterisation of coronary artery disease in patients with human immunodeficiency virus (HIV) infection undergoing percutaneous coronary intervention. Eurointervention 12(14): 1757-1765, 2017

Rapid progression of atherosclerotic coronary artery disease in patients with human immunodeficiency virus infection. Heart and Vessels 20(4): 171-174, 2005

Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection. American Journal of Cardiology 104(2): 216-222, 2009

Coronary artery lesions and human immunodeficiency virus infection. Research In Virology. 144(3): 225-231, 1993

Progression of coronary artery calcium in men affected by human immunodeficiency virus infection. International Journal of Cardiovascular Imaging 28(4): 935-941, 2012

Coronary Artery Disease in the Human Immunodeficiency Virus Seropositive Population. American Journal of Therapeutics 23(1): E224-E231, 2016

Carotid artery disease and human immunodeficiency virus (HIV) infection. Neurologia 24(5): 318-330, 2009

A Case of Isolated Coronary Artery Ectasia in the Setting of Chronic Inflamation From human Immunodeficiency Virus Infection. Journal of the Louisiana State Medical Society 168(4): 125-126, 2017

Risk of coronary artery disease in individuals infected with human immunodeficiency virus. The Brazilian Journal of Infectious Diseases 15(6): 521-527, 2011

Risk of coronary artery disease in individuals infected with human immunodeficiency virus. Brazilian Journal of Infectious Diseases 15(6): 521-527, 2012

Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. Centers for Disease Control and Prevention. Mmwr. Recommendations and Reports 48(Rr-13): 1-27, 29-31, 2000

Infection with the human immunodeficiency virus type 1 and vascular inflammatory disease. Clinical and Experimental Rheumatology 22(6 Suppl 36): S87-S93, 2004

Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection. Arteriosclerosis Thrombosis and Vascular Biology 34(5): 1085-1092, 2014

Pulmonary arterial hypertension in human immunodeficiency virus infection: a disease without hope?. Indian Journal of Chest Diseases and Allied Sciences 51(4): 203-206, 2010